OBJECTIVE: The obese (ob) gene encodes leptin which inhibits appetite and stimulates thermogenesis. Serum leptin concentrations are determined by total body fat mass, but the in¯uence of visceral fat accumulation and other metabolic factors have not been clinically determined. METHODS: We determined the correlations between serum leptin concentrations and the total body fat mass, abdominal fat mass, abdominal fat distribution (estimated by ultrasound), and circulating metabolic factors in 104 Japanese healthy subjects (11 men and 93 women). In addition, the effect of food restriction (30 kcal/kg desired body weight/day) for four weeks on serum leptin concentrations were also examined in 30 women. RESULTS: There was a signi®cant correlation between serum leptin concentrations and total body fat mass (r 0.708, P`0.0001), the percentage of body fat (r 0.561, P`0.001), and the body mass index (BMI, r 0.630, P`0.001). Serum leptin concentrations were correlated with the abdominal wall preperitoneal and subcutaneous fat pad thickness, but not the abdominal wall fat index (AFI). Serum leptin concentrations were also correlated with serum immunoreactive insulin (IRI), but not glucose, or free fatty acid (FFA) concentrations. The weight loss after food restriction for four weeks signi®cantly (P 0.016) reduced the serum leptin concentrations with a signi®cant reduction of body fat mass, serum glucose, IRI and FFA concentrations. However, there was no signi®cant correlation of the percentage change in serum leptin concentrations to that in body fat mass after food restriction. CONCLUSION: Serum leptin concentrations are well correlated with the total body fat mass in healthy subjects. Differences in abdominal fat distribution do not appear to be related to a difference in the in vivo leptin production from adipose tissue.
Introduction
The obese (ob) gene was recently identi®ed as being involved in the regulation of energy balance in genetically obese mice. 1 The ob gene encodes the protein, leptin, that plays an important role in the regulation of food consumption and body weight. Since leptin inhibits appetite and stimulates thermogenesis in rodents, 2±4 this peptide is believed to act as a satiety factor in the hypothalamus. Recently, evidence has been accumulated that the ob gene expression is modi®ed by various kinds of humoral factors such as insulin, glucocorticoids, estrogen, and cytokines which involve the regulation of food intake. 5±10 However, an interrelation between the ob gene expression and circulating metabolic factors has not been clinically determined.
In human studies, serum leptin concentrations have recently been reported to be correlated with the percentage of body fat, suggesting that most obese people may be insensitive to increased levels of the anorexigenic peptide, leptin which was endogenously overproduced from adipose tissues. 11 On the other hand, visceral fat mass is related to the elevation of circulating metabolic factors such as insulin, 12 which may affect leptin production from the adipocytes. 5, 7, 8 It is possible that there may be a difference in the leptin production between the visceral and subcutaneous adipose tissues. However, whether the regional differences of visceral fat mass may affect serum leptin concentrations is still unknown in humans.
In the present study, we determined correlations between serum leptin concentrations and metabolic parameters of body fat adiposity, abdominal fat distribution, and circulating metabolic factors in healthy Japanese subjects who have no metabolic disorders. In addition, the effect of body weight loss after food restriction on serum leptin concentrations was investigated.
Subjects and methods

Subjects
The present study included 104 healthy Japanese subjects (11 men and 93 women, mean age: 49.7 AE 1.0 y old, and Body Mass Index (BMI): 23.9 AE 0.3 kg/m 2 ). No subject was receiving medications for any metabolic disorders. All subjects were fully informed as to the nature of the study and provided consent. The study was conducted in accordance with the provisions of the Declaration of Helsinki, as amended in Tokyo in 1975 and Venice 1989. The study was approved by the Institutional Review Board of the Department of Medicine, Gunma University, School of Medicine (Maebashi, Japan).
In the second study which examined the effect of food restriction for four weeks on serum leptin concentrations, 30 women were randomly included from all subjects in the ®rst study, and gave their informed consent to undergo food restriction.
Study protocols
All subjects included in the ®rst study were not requested to follow any particular diet prior to blood sampling. Blood specimens were collected from the cubital vein in the early morning after overnight fasting. Following immediate centrifugation, the obtained sera were stored at 7 70 C for the measurement of serum leptin, immunoreactive insulin (IRI), glucose and free fatty acid (FFA) concentrations. Total body fat mass and the percentage of body weight (% body fat) were measured by bioelectric impedance analysis method (TBF-101, Tanita Inc., Tokyo, Japan). Abdominal wall subcutaneous and preperitoneal fat pad thickness was estimated by using ultrasonography (SDL-310, Shimazu Industrial Ltd., Tokyo, Japan), according to the method previously reported by Suzuki et al. 13 The abdominal wall fat index (AFI), which has been reported to be well correlated with visceral fat mass, 13 was calculated by dividing the maximum of abdominal wall preperitoneal fat thickness by the minimum of abdominal wall subcutaneous fat pad thickness.
To study the effect of body weight loss due to food restriction, thirty healthy women (the average of age: 48.4 AE 1.8 y old, the average of the Body Mass Index (BMI): 25.1 AE 0.5 kg/m 2 ) received food restriction therapy (30 kcal/kg desired body weight/day) for four weeks. The desired body weight was calculated according to the modi®cation of Broca's calculation method (The Desired Body Weight (kg) (Height (cm) 7 100) 6 0.9 (kg). The diet composition was not changed during the whole observation period after the start of food restriction. Changes in body fat mass, abdominal fat distribution, and circulating metabolic factors including serum leptin concentration were measured before and at four weeks after the start of food restriction, as described above.
Assays
Circulating glucose and FFA concentrations were measured with an automatic analyzer using a glucose oxidase method and an enzymatic method, respectively. Serum leptin concentration was assayed with a radioimmunoassay (RIA) kit, obtained from Linco Research, Inc. (St. Charles, Mo, USA). 2, 12 The limit of sensitivity for human leptin assay was 0.5 ng/ml. Serum IRI concentration was also assayed with a commercially available RIA kit (Phadeceph Insulin Kit, Pharmacia Japan, Tokyo, Japan).
Statistical analysis
All data were expressed as means AE s.e. The correlation was evaluated using the linear regression analysis. The values before and after food restriction were compared by means of paired t-test. A value of P`0.05 was considered to be statistically signi®cant. Tables 1 and 2 show the simple correlation coef®-cients and statistical signi®cance among serum leptin concentrations, body fat mass, % body fat, body mass index (BMI), abdominal wall fat pad thickness, fasting glucose, serum IRI, FFA concentrations, and the P-values, respectively. As shown in Figure 1 , there were signi®cant positive correlations between the serum leptin concentration and the BMI (r 0.630, P`0.001; Figure 1a ), % body fat (r 0.561, P`0.001; Figure 1b ) and total body fat mass (r 0.708, P`0.001; Figure 1c ), respectively. The strongest correlation was between total body fat mass and serum leptin concentration.
Results
With regard to the abdominal wall fat distribution, serum leptin concentrations were signi®cantly (P`0.001) correlated with both abdominal wall subcutaneous ( Figure 2a ) and preperitoneal ( Figure 2b ) fat pad thickness, but not the AFI (Figure 2c ). Thus, serum leptin concentration may not be associated with regional difference of abdominal fat distribution assessed with the AFI. Serum IRI concentrations were signi®cantly correlated with serum leptin, and glucose concentrations, total body fat mass, BMI, preperitoneal fat pad thickness, and AFI, but not % body fat, or subcutaneous fat pad thickness (Tables 1  and 2 ). Serum FFA concentration was not correlated with any of the factors measured in this study. Table 3 shows the changes of all metabolic factors measured before and at four weeks after the start of food restriction in the second study. The food restriction for four weeks signi®cantly (P`0.001) decreased the total body fat mass by 1.8 kg. As shown in Figure 3 , food restriction signi®cantly (P 0.016) reduced serum leptin concentration by 79% of its initial value. However, the % change of total body fat mass by food restriction was not (Table 3) . However, neither abdominal wall preperitoneal, subcutaneous fat pad thickness nor the AFI was signi®cantly reduced by food restriction for four weeks.
Discussion
In the present study, we found strong correlations between serum leptin concentrations and the total body fat mass, % body fat, and BMI in healthy Japanese subjects who were of normal weight (23.9 AE 0.3 kg/m 2 ). These results are consistent with previous observations by several investigators. 10, 14 However, since the present studies did not include obese subjects, the extent to which the results obtained herein apply to obese individuals is unclear.
In addition, we found that a reduction of 1.8 kg (9% of initial value) in total body fat mass by food restriction for four weeks was associated with a reduction of serum leptin concentrations. These data indicate that an increase of serum leptin concentration should re¯ect the greater production of leptin from increased body fat mass. However, it is possible that the reduction of serum leptin concentration after food restriction may be in¯uenced by other effects of recent dietary manipulation, since there was no obvious correlation between the % changes in total body fat mass and serum leptin concentration.
The present study demonstrated that serum leptin concentrations was not associated with a regional difference of abdominal wall fat mass, evaluated by the ultrasonography method. Although it has been reported that the AFI is a good indicator of visceral fat deposition, 13 the present study demonstrated that both preperitoneal and subcutaneous fat pad thickness were signi®cantly correlated with serum leptin concentration, while the AFI was not at all. This observation indicated that the absolute value (fat pad thickness) should re¯ect abdominal fat mass more than the AFI which has been reported to be well correlated with the V/S ratio, calculated from the CT scanning image. We would like to emphasize the contrast between the strong association of the AFI to serum insulin concentration and the absence of any association between the AFI and serum leptin concentration. This suggests that whereas intra-abdominal fat is a determinant of the fasting insulin concentration, it may not be a determinant of serum leptin concentration. It has recently been reported that ob mRNA expression varies from region to region in adipose tissues of rodents and humans. 15±17 The epididymal and perirenal fat pads had higher ob mRNA levels than subcutaneous fat in the rat. 15 Insulin infusion increased ob mRNA expression in epididymal and perirenal fat pads, but not in the subcutaneous fat of the rat. 16 In humans, the ob mRNA expression increased in omental fat cells from massively obese humans.
14 In contrast, another human study demonstrated that the ob mRNA level in the subcutaneous adipose tissue was higher than those in the omental, retroperitoneal, and mesenteric adipose tissue. 17 The exact interrelation between leptin production and regional fat distribution has not been clinically established in the abdomen. In the present data, serum leptin concentration was correlated with both subcutaneous and preperitoneal fat pad thickness, but not the AFI, which is thought to be well related to visceral fat mass. In the second study, the reduction of body fat mass by food restriction for four weeks signi®cantly reduced serum leptin concentration, although the abdominal wall fat pad thickness and the AFI were not changed. From those data, it was suggested that serum leptin concentration may be associated with the total body fat mass, rather than the increase of visceral fat mass in Japanese healthy subjects who are normal weight.
The present data show that there was a strong correlation between circulating leptin concentration and total body fat mass, indicating that the increased fat mass is able to produce large amounts of leptin in obese subjects. Thus, there is no evidence that the metabolic, anorexigenic signal from adipose tissues to the hypothalamus (an increase of circulating leptin), which should regulate food intake, is de®cient even in massively obese subjects. Recently, it was demonstrated that, in rodents, exogenously administered leptin acts on the hypothalamus to affect neuropeptide Y mRNA expression, inhibiting food intake. 18 There is a possibility that the long-term, excessive production of leptin from an increased fat mass may result in a reduction of the sensitivity to circulating leptin in the feeding center of the hypothalamus in obese subjects, for example down regulation of leptin receptors. Another possibility is the existence of a genetic defect of leptin receptor function. 19, 20 In contrast, the recent study which examined the cerebrospinal¯uid : plasma leptin ratio in obese subjects indicated that the reduced ef®ciency of brain leptin delivery among obese individuals with high plasma leptin levels results in apparent leptin resistance. 21 However, it is unlikely that this observation can fully explain the discrepancy between high leptin concentration and hyperphagia in obese subjects, and further studies should be necessary to clarify this issue in humans.
Conclusion
Serum leptin concentration well re¯ects the total body fat mass in human subjects. Differences in the abdominal fat distribution are not related to any differences in the in vivo leptin production from adipose tissues. Figure 3 Changes in the serum leptin concentrations of 30 healthy Japanese subjects before and after the weight loss by food restriction (30 kcal/kg desired body weight/day) for four weeks. Open circles and horizontal bars represent mean AE s.e. before and after food restriction for four weeks. Closed circles represent serum leptin concentration before and after food restriction for four weeks in each subject.
